# § 520.1604   Oclacitinib.

(a) *Specifications.* Each tablet or chewable tablet contains 3.6, 5.4, or 16 milligrams (mg) of oclacitinib as oclacitinib maleate.


(b) *Sponsor.* See No. 054771 in § 510.600(c) of this chapter.


(c) *Conditions of use*—(1) *Amount.* Administer orally 0.18 to 0.27 mg/per pound of body weight (0.4 to 0.6 mg/kg body weight) twice daily for up to 14 days; then administered once daily for maintenance therapy.


(2) *Indications for use.* For control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.


(3) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.



---

[N] [78 FR 42007, July 15, 2013, as amended at 88 FR 55563, Aug. 16, 2023]




